GuidelinesGuidelines for management of intra-abdominal infections
Section snippets
Work group leaders
J.M. Constantin, Clermont-Ferrand
P.F. Laterre, Brussels
R. Gauzit, Paris
K. Asehnoune, Nantes
C. Paugam, Clichy
P.F. Perrigault, Montpellier
Work groups
Experts representing their learned society are designated by the society's acronym. Invited experts are designated by their specialty.
Diagnosis of intra-abdominal infection
J.M. Constantin, Clermont-Ferrand (Sfar)
J. Cazejust, Paris (Radiologist)
E. Grégoire, Marseille (Surgeon)
M. Leone, Marseille (Sfar)
T. Lescot, Paris (Anaesthetist-Intensive Care Physician)
J. Morel, Saint-Étienne (Anaesthetist-Intensive Care Physician)
A. Sotto, Nîmes (SPILF)
J.J. Tuech, Rouen (AFCD)
Infection source control
Review committee
K. Asehnoune, Nantes (Anaesthetist-Intensive Care Physician), P. Augustin, Paris (Anaesthetist-Intensive Care Physician), C. Brigand, Strasbourg (AFC), J.P. Bru, Annecy (SPILF), J.M. Constantin, Clermont-Ferrand (Sfar), C. Dahyot, Poitiers (Anaesthetist-Intensive Care Physician), C. Daurel, Caen (Microbiologist), L. Dubreuil, Lille (Microbiologist), G. Dufour, Paris (Anaesthetist-Intensive Care Physician), R. Dumont, Nantes (Anaesthetist-Intensive Care Physician), H. Dupont, Amiens (Sfar),
Recommendations for community-acquired intra-abdominal infections
Although many clinical trials have been devoted to the management of community-acquired intra-abdominal infections, they were very often purely observational and are unable to answer all of the questions raised. Clinical practices associated with a high-level of agreement of the experts are often based on common sense or usual practice and cannot be readily justified by randomized clinical trials.
Only limited French and European data are available concerning the epidemiology of bacterial
Recommendations for paediatric intra-abdominal infections
Very few clinical studies, often consisting of poor quality observational studies, have been published in the literature and cannot be used as a basis for clear and definitive diagnostic or therapeutic clinical practice guidelines.
There are no radiological or laboratory diagnostic features specific to children.
The data of the literature are insufficient to recommend one particular antibiotic therapy rather than another. Nevertheless, empirical therapy must comprise an antibiotic active on
Recommendations for healthcare-associated intra-abdominal infections (nosocomial and postoperative)
The literature on healthcare-associated infections is predominantly devoted to postoperative peritonitis and is very often based on observational studies. Many questions remain totally unexplored. Clinical practice guidelines, for which a strong agreement was reached by the experts, are often based on extrapolation from management practices in other diseases such as septic shock.
French data concerning the epidemiology of bacterial resistance are based on studies published by several teams over
References (96)
- et al.
Management and outcome of high-risk peritonitis: a retrospective survey 2005–2009
Int J Infect Dis
(2011) - et al.
Emergency laparoscopic management of perforated sigmoid diverticulitis: a promising alternative to more radical procedures
J Am Coll Surg
(2008) - et al.
[Conservative laparoscopic treatment of diverticular peritonitis]
J Chir
(2009) - et al.
Factors associated with multidrug-resistant bacteria in secondary peritonitis: impact on antibiotic therapy
Clin Microbiol Infect
(2006) - et al.
Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)
Int J Antimicrob Agents
(2010) - et al.
Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B
Diagn Microbiol Infect Dis
(2002) - et al.
Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections
Int J Antimicrob Agents
(2009) - et al.
A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections
Clin Microbiol Infect
(2010) - et al.
A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units
Clin Microb Infect
(2011) - et al.
De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality?
J Crit Care
(2010)
A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs. ≥ 5 days in community-acquired intraabdominal infection
J Gastrointest Surg
Predictive value of white blood cell count and C-reactive protein in children with appendicitis
J Pediatr Surg
Diagnosing pediatric appendicitis: usefulness of laboratory markers
Am J Amerg Med
Bacteriologic epidemiology and empirical treatment of pediatric complicated appendicitis
Diagn Microbiol Infect Dis
Bacterial studies of complicated appendicitis over a 20-year period and their impact on empirical antibiotic treatment
J Pediatr Surg
Can failure of percutaneous drainage of postoperative abdominal abscesses be predicted?
Am J Surg
La tomodensitométrie et le drainage percutanée modifient les indications de réintervention après chirurgie digestive
Ann Fr Anesth Reanim
sTREM-1 is a potential useful biomarker for exclusion of ongoing infection in patients with secondary peritonitis
Cytokine
Procalcitonin ratio indicates successful surgical treatment of abdominal sepsis
Surgery
Prospective evaluation of virulence factors of enterococci isolated from patients with peritonitis: impact on outcome
Diagn Microbiol Infect Dis
Factors predicting morbidity and mortality in emergency colorectal procedures in elderly patients
Arch Surg
Factors predicting in-hospital mortality of patients with diffuse peritonitis from perforated colonic diverticulitis
Ann Ital Chir
Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis
J Antimicrob Chemother
Prognostic factors of the mortality of postoperative intraabdominal infections
Infection
Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli
Scand J Infect Dis
Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study
J Antimicrob Chemother
Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis
Crit Care
Prise en charge hémodynamique du sepsis sévère (nouveau-né exclus)
Conférence de consensus commune organisée par la Sfar
Laparoscopic correction of perforated peptic ulcer: first choice?. A review of literature
Surg Endosc
Laparoscopy for abdominal emergencies: evidence-based guidelines of the European Association for Endoscopic Surgery
Surg Endosc
Laparoscopic peritoneal lavage for generalized peritonitis due to perforated diverticulitis
Br J Surg
Perforated diverticulitis managed by laparoscopic lavage
ANZ J Surg
Percutaneous drainage of 300 intraperitoneal abscesses with long-term follow-up
Cardiovasc Intervent Radiol
Determinants for successful percutaneous image-guided drainage of intra-abdominal abscess
Arch Surg
Differences in morbidity and mortality with percutaneous versus open surgical drainage of postoperative intra-abdominal infections: a review of 686 cases
Am Surg
Recurrent abdominal and pelvic abscesses: incidence, results of repeated percutaneous drainage, and underlying causes in 956 drainages
AJR Am J Roentgenol
Percutaneous drainage of postoperative abdominal abscess with limited accessibility: preexisting surgical drains as alternative access route
Radiology
Mortality and morbidity of planned relaparotomy versus relaparotomy on demand for secondary peritonitis
Br J Surg
Factors affecting mortality in generalized postoperative peritonitis: multivariate analysis in 96 patients
World J Surg
Planned relaparotomies for advanced, established peritonitis from colonic origin
Acta Chir Belg
Comparison of on-demand vs. planned relaparotomy for treatment of severe intra-abdominal infections
Croat Med J
Comparison of on-demand vs. planned relaparotomy strategy in patients with severe peritonitis: a randomized trial
JAMA
Epidemiology, management, and prognosis of secondary non-postoperative peritonitis: a French prospective observational multicenter study
Surg Infect
Antimicrobial susceptibility of intra-abdominal gram-negative bacilli from Europe: SMART Europe 2008
Eur J Clin Microbiol Infect Dis
Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients
Arch Surg
Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery
Eur J Clin Microbiol Infect Dis
Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs
Br J Clin Pharmacol
Cited by (109)
Reducing the duration of antibiotic therapy in surgical patients through a specific nationwide antimicrobial stewardship program. A prospective, interventional cohort study
2023, International Journal of Antimicrobial AgentsCarbapenem prescriptions: Compliance with guidelines in a pediatric hospital
2023, Archives de PediatrieSedation in intensive care unit
2022, Anesthesie et ReanimationAmikacin in emergency surgery: How to dose it optimally?
2022, Anaesthesia Critical Care and Pain MedicineCitation Excerpt :For example, they may be used as antimicrobial prophylaxis for urological procedures [2]. Amikacin is a recommended option for empirical therapy of healthcare-associated intra-abdominal infections (IAI) in both non-critically ill and critically ill patients, those being common surgical emergencies [3,4]. Current guidelines suggest a dosage of 15−20 mg/kg every 24 h (q24) for amikacin in this indication [4].
Candida and Candidiasis
2022, Encyclopedia of Infection and Immunity